INTAL

This brand name is authorized in Australia, Japan, Turkey, United Kingdom

Active ingredients

The drug INTAL contains one active pharmaceutical ingredient (API):

1 Cromoglicic acid
UNII Q2WXR1I0PK - CROMOLYN SODIUM

Sodium cromoglicate (Cromoglicic acid) inhibits the activation of many of the cell types involved in the development and progression of asthma. Thus, sodium cromoglicate inhibits the release of inflammatory mediators including cytokines from mast cells and reduces the chemotactic activity of eosinophils and neutrophils.

Read about Cromoglicic acid

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
INTAL CFC-FREE Pressurised inhalation, suspension Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R03BC01 Cromoglicic acid R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BC Antiallergic agents, excl. corticosteroids
Discover more medicines within R03BC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 8334P, 8767K
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 137771
Country: JP 医薬品医療機器総合機構 Identifier(s): 2259701G1063
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699582750094, 8699809522619, 8699809522633

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.